Opencell Technologies, Inc.

St. Louis, MO

UEI
Q6HJH3BNJH96
CAGE
514S4
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4320 Forest Park Ave #201, St. Louis, MO 63108, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Developing a platform for multiplexed large payload delivery R43CA239955 National Cancer Institute (NIH) $298,853
Establishing the poros intracellular delivery system as a platform for cellular therapeutics R44CA233153 National Cancer Institute (NIH) $4,100,108
Establishing the poros intracellular delivery system as a platform for cellular therapeutics R43CA233153 National Cancer Institute (NIH) $247,405
Mist system for simultaneous parallel intracellular delivery & transfection R44GM112398 National Institutes of Health $899,488
Sttr phase i: polymer electrosonic actuation microarray: low-cost tool for transfection of biological cells 1321466 National Science Foundation $225,000

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Opencell Technologies, Inc. registered in SAM.gov?

Yes. Opencell Technologies, Inc.'s SAM.gov registration is active through September 28, 2027.

What is Opencell Technologies, Inc.'s most recent federal award?

Opencell Technologies, Inc.'s most recent federal grant award is Developing a platform for multiplexed large payload delivery (R43CA239955), from National Cancer Institute (NIH), on September 1, 2019.

On GovTribe

See Opencell Technologies, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login